This Part 1 of Pain Assessment and Management will review assessment of acute and chronic pain syndromes to enable pharmacist to make appropriate pharmacotherapeutic recommendations for patients with life-limiting illnesses or are approaching the end of their lives. Non-opioid, opioid, and adjuvant medications will be discussed.
Fee
$15.00
Activity Type
- Knowledge
Target Audience(s)
- Pharmacist
Accreditation(s)
CPE Consultants, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education
|
|
![]() |
|
Co-Sponsor(s)
Profero Team, LLC
This Part 1 of Pain Assessment and Management will review assessment of acute and chronic pain syndromes to enable pharmacist to make appropriate pharmacotherapeutic recommendations for patients with life-limiting illnesses or are approaching the end of their lives. Non-opioid, opioid, and adjuvant medications will be discussed.
Objectives
- Describe pain pathophysiology
- Explain strategies for assessing pain
- Identify pharmacologic management of pain in patients with life-limiting illnesses
Speaker(s)/Author(s)
Phyllis Grauer, PharmD Brief Bio : Phyllis Grauer, PharmD has been a pain, palliative care and hospice clinical pharmacist for more than 30 years. She is a Certified Pain Educator (CPE), is Board Certified in Geriatric Pharmacy (BCGP) and a Chemical Dependency Counselor Assistant (CDCA). Phyllis received a BS in Pharmacy from The Ohio State University College of Pharmacy and a PharmD from University of Kansas School of Pharmacy. She founded a nationwide hospice and palliative care clinical consulting company, has lectured extensively and has taught at Ohio State University, Cedarville University, Ohio Northern University and University of Findlay Schools of Pharmacy and has multiple publications. She is currently the owner and Specialty Practice Clinical Consultant at Cha?is Consulting, LLC. She provides educational programs, patient specific consultation in the areas of pain and symptom medication management, hospice and palliative care, controlled substance prescribing and dispensing, and substance use disorder. |
Activity Number
0864-9999-22-030-H08-P
Release Date:
Jun 28, 2022
Credit Expiration Date:
Jun 28, 2025